Targeting the Wnt/ββ-catenin signaling pathway in human cancers

Author： Yao Hisayuki   Ashihara Eishi   Maekawa Taira  

Publisher： Informa Healthcare

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.15, Iss.7, 2011-07, pp. : 873-887

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Wnt-ow of Opportunity: Targeting the Wnt/&bgr;-Catenin Pathway in Breast Cancer

By  

Current Drug Targets, Vol. 11, Iss. 9, 2010-09 ,pp. : 1074-1088

Bentham Science Publishers

Access to resources Recommend Favorite

The Potential for Targeting Oncogenic WNT/&bgr; -Catenin Signaling in Therapy

By  

Current Drug Targets, Vol. 9, Iss. 7, 2008-07 ,pp. : 532-547

Bentham Science Publishers

Access to resources Recommend Favorite

Wnt / &bgr;-Catenin Signaling Pathway as Novel Cancer Drug Targets

By  

Current Cancer Drug Targets, Vol. 4, Iss. 8, 2004-12 ,pp. : 653-671

Bentham Science Publishers

Access to resources Recommend Favorite

Epigenetic Alterations of the Wnt/&bgr; -Catenin Pathway in Human Disease

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 7, Iss. 1, 2007-03 ,pp. : 13-21

Bentham Science Publishers

Access to resources Recommend Favorite

Molecular Components of Wnt/β-catenin Pathway As Therapeutic Targets For Upper Gastrointestinal Cancers

By  

Clinical Cancer Drugs, Vol. 2, Iss. 2, 2015-10 ,pp. : 72-79

Bentham Science Publishers

Access to resources Recommend Favorite